Genzyme Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genzyme stocks.

Genzyme Stocks Recent News

Date Stock Title
Apr 27 PTCT PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations
Apr 27 BMRN 4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
Apr 27 BMRN Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Apr 26 PTCT Sector Update: Health Care Stocks Edge Higher Late Afternoon
Apr 26 BMRN BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Apr 26 PTCT Q1 2024 PTC Therapeutics Inc Earnings Call
Apr 26 BMRN BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
Apr 26 BMRN Pfizer hemophilia gene therapy arrives in US to uncertain future
Apr 26 PTCT PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Apr 26 PTCT PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
Apr 26 PTCT Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
Apr 25 PTCT PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review
Apr 25 PTCT PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M
Apr 25 PTCT PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Apr 25 BMRN Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Apr 25 BMRN BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
Apr 25 BMRN BioMarin drops drug programs in pipeline cull
Apr 25 BMRN Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
Apr 25 BMRN Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...
Apr 25 BMRN BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
Genzyme

Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.

Browse All Tags